These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 32513839)

  • 1. Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters.
    Torralva R; Eshleman AJ; Swanson TL; Schmachtenberg JL; Schutzer WE; Bloom SH; Wolfrum KM; Reed JF; Janowsky A
    J Pharmacol Exp Ther; 2020 Sep; 374(3):376-391. PubMed ID: 32513839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
    Seely KA; Brents LK; Franks LN; Rajasekaran M; Zimmerman SM; Fantegrossi WE; Prather PL
    Neuropharmacology; 2012 Oct; 63(5):905-15. PubMed ID: 22771770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
    Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
    Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for
    Obeng S; Wilkerson JL; León F; Reeves ME; Restrepo LF; Gamez-Jimenez LR; Patel A; Pennington AE; Taylor VA; Ho NP; Braun T; Fortner JD; Crowley ML; Williamson MR; Pallares VLC; Mottinelli M; Lopera-Londoño C; McCurdy CR; McMahon LR; Hiranita T
    J Pharmacol Exp Ther; 2021 Mar; 376(3):410-427. PubMed ID: 33384303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.
    Torralva R; Janowsky A
    J Pharmacol Exp Ther; 2019 Nov; 371(2):453-475. PubMed ID: 31492824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
    Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
    Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment.
    Wu Q; Hwang CK; Zheng H; Wagley Y; Lin HY; Kim DK; Law PY; Loh HH; Wei LN
    FASEB J; 2013 Feb; 27(2):522-35. PubMed ID: 23085997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Characterization of Substituted Nitazenes at
    Kozell LB; Eshleman AJ; Wolfrum KM; Swanson TL; Bloom SH; Benware S; Schmachtenberg JL; Schutzer KA; Schutzer WE; Janowsky A; Abbas AI
    J Pharmacol Exp Ther; 2024 Apr; 389(2):219-228. PubMed ID: 38453524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
    Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A
    J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
    Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
    Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
    Zhang J; Haddad GG; Xia Y
    Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of motility in isolated horse small intestine is mediated by κ but not µ opioid receptors.
    Menozzi A; Pozzoli C; Zullian C; Poli E; Serventi P; Bertini S
    Equine Vet J; 2012 May; 44(3):368-70. PubMed ID: 21883413
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.